OKYO Pharma gains after positive results from Phase 2 dry eye disease trial
Shares of OKYO Pharma (NASDAQ:OKYO) rose more than 7% in premarket trade on Friday, on additional key findings from analyses ...
Shares of OKYO Pharma (NASDAQ:OKYO) rose more than 7% in premarket trade on Friday, on additional key findings from analyses ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.